Improving prognosis and assessing adjuvant chemotherapy benefit in locally advanced rectal cancer with deep learning for MRI: A retrospective, multi-cohort study
文献类型:期刊论文
作者 | Zhang, Song4,5![]() ![]() ![]() |
刊名 | RADIOTHERAPY AND ONCOLOGY
![]() |
出版日期 | 2023-11-01 |
卷号 | 188页码:9 |
关键词 | Locally advanced rectal cancer Magnetic resonance imaging Prognosis Adjuvant chemotherapy Deep learning |
ISSN号 | 0167-8140 |
DOI | 10.1016/j.radonc.2023.109899 |
通讯作者 | Li, Zhenhui(lizhenhui@kmmu.edu.cn) ; Liu, Zhenyu(zhenyu.liu@ia.ac.cn) ; Tian, Jie(jie.tian@ia.ac.cn) |
英文摘要 | Purpose: Adjuvant therapy is recommended to minimize the risk of distant metastasis (DM) and local recurrence (LR) in patients with locally advanced rectal cancer (LARC). However, its role is controversial. We aimed to develop a pretreatment MRI-based deep learning model to predict LR, DM, and overall survival (OS) over 5 years after surgery and to identify patients benefitting from adjuvant chemotherapy (AC).Materials and methods: The multi-survival tasks network (MuST) model was developed in a primary cohort (n = 308) and validated using two external cohorts (n = 247, 245). An AC decision tree integrating the MuST-DM score, perineural invasion (PNI), and preoperative carbohydrate antigen 19-9 (CA19-9) was constructed to assess chemotherapy benefits and aid personalized treatment of patients. We also quantified the prognostic improvement of the decision tree.Results: The MuST network demonstrated high prognostic accuracy in the primary and two external cohorts for the prediction of three different survival tasks. Within the stratified analysis and decision tree, patients with CA19-9 levels > 37 U/mL and high MuST-DM scores exhibited favorable chemotherapy efficacy. Similar results were observed in PNI-positive patients with low MuST-DM scores. PNI-negative patients with low MuST-DM scores exhibited poor chemotherapy efficacy. Based on the decision tree, 14 additional patients benefiting from AC and 391 patients who received overtreatment were identified in this retrospective study.Conclusion: The MuST model accurately and non-invasively predicted OS, DM, and LR. A specific and direct tool linking chemotherapy decisions and benefit quantification has also been provided.(c) 2023 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 188 (2023) 1-9 |
WOS关键词 | TOTAL MESORECTAL EXCISION ; MEDIAN FOLLOW-UP ; POSTOPERATIVE CHEMORADIOTHERAPY ; PREOPERATIVE RADIOTHERAPY ; PERSONALIZED APPROACH ; SURVIVAL ; RECURRENCE ; COLON ; CHEMORADIATION ; MULTICENTER |
资助项目 | National Key R&D Program of China, China[2021YFF1201003] ; National Natural Science Foundation of China, China[62333022] ; National Natural Science Foundation of China, China[92059103] ; National Natural Science Foundation of China, China[92259301] ; National Natural Science Foundation of China, China[92159301] ; National Natural Science Foundation of China, China[82001986] ; National Natural Science Foundation of China, China[82360345] ; Beijing Natural Science Foundation, China[JQ23034] ; Yunnan Basic Research Project, China[202201AT070010] |
WOS研究方向 | Oncology ; Radiology, Nuclear Medicine & Medical Imaging |
语种 | 英语 |
WOS记录号 | WOS:001081328900001 |
出版者 | ELSEVIER IRELAND LTD |
资助机构 | National Key R&D Program of China, China ; National Natural Science Foundation of China, China ; Beijing Natural Science Foundation, China ; Yunnan Basic Research Project, China |
源URL | [http://ir.ia.ac.cn/handle/173211/52987] ![]() |
专题 | 自动化研究所_中国科学院分子影像重点实验室 |
通讯作者 | Li, Zhenhui; Liu, Zhenyu; Tian, Jie |
作者单位 | 1.Chinese Acad Sci, Inst Automat, 95 Zhongguancun East Rd, Beijing 100190, Peoples R China 2.Kunming Med Univ, Yunnan Canc Hosp, Yunnan Canc Ctr, Dept Radiol,Affiliated Hosp 3, Kunming, Yunnan, Peoples R China 3.Yunnan Canc Hosp, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China 4.Chinese Acad Sci, Inst Automation, CAS Key Lab Mol Imaging, Beijing Key Lab Mol Imaging, Beijing, Peoples R China 5.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China 6.Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai, Peoples R China 7.Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China 8.Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou, Guangdong, Peoples R China 9.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Engn Med, Beijing, Peoples R China 10.Beihang Univ, Key Lab Big Data Based Precis Med, Minist Ind & Informat Technol, Beijing, Peoples R China |
推荐引用方式 GB/T 7714 | Zhang, Song,Cai, Guoxiang,Xie, Peiyi,et al. Improving prognosis and assessing adjuvant chemotherapy benefit in locally advanced rectal cancer with deep learning for MRI: A retrospective, multi-cohort study[J]. RADIOTHERAPY AND ONCOLOGY,2023,188:9. |
APA | Zhang, Song.,Cai, Guoxiang.,Xie, Peiyi.,Sun, Caixia.,Li, Bao.,...&Tian, Jie.(2023).Improving prognosis and assessing adjuvant chemotherapy benefit in locally advanced rectal cancer with deep learning for MRI: A retrospective, multi-cohort study.RADIOTHERAPY AND ONCOLOGY,188,9. |
MLA | Zhang, Song,et al."Improving prognosis and assessing adjuvant chemotherapy benefit in locally advanced rectal cancer with deep learning for MRI: A retrospective, multi-cohort study".RADIOTHERAPY AND ONCOLOGY 188(2023):9. |
入库方式: OAI收割
来源:自动化研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。